Bulimia Nervosa, 5-HTTLPR Polymorphism and Treatment Response to Four SSRIs
Authors:
- Stefano ErzegovesiSEStefano Erzegovesi
- Chiara RiboldiCRChiara Riboldi
- Daniela Di BellaDBDaniela Di Bella
- Daniela Di MolfettaDMDaniela Di Molfetta
- Francesca PsyD MapelliFMFrancesca PsyD Mapelli
- Bruna PsyD NegriBNBruna PsyD Negri
- Micaela PsyD TenaceMTMicaela PsyD Tenace
- Laura BellodiLBLaura Bellodi
- 1 December 2004
- journal article
- letter
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 24 (6) , 680-682
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment responseThe Pharmacogenomics Journal, 2002
- A Placebo-Controlled Study of Fluoxetine in Continued Treatment of Bulimia Nervosa After Successful Acute Fluoxetine TreatmentAmerican Journal of Psychiatry, 2002
- Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamineMolecular Psychiatry, 1998
- Long-Term Fluoxetine Treatment of Bulimia NervosaThe British Journal of Psychiatry, 1995
- The Yale-Brown-Cornell eating disorder scale: Development, use, reliability and validityJournal of Psychiatric Research, 1994